Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Select your species
Stanniocalcin 1 downregulation is responsible for sorafenib-induced cardiotoxicity through activated ROS (zeige ROS1 ELISA Kits) generation.
the results suggest that the CaSR is critical for Ca(2+) homeostasis in larval zebrafish exposed to low environmental Ca(2+) levels, possibly owing to its modulation of stanniocalcin mRNA expression.
This study showed that stanniocalcin 1 (stc1)modulates cation levels in trpm7 (zeige TRPM7 ELISA Kits) mutants and in the wild type; levels of cations are restored to normal in trpm7 (zeige TRPM7 ELISA Kits) mutants when stc1 activity is blocked.
STC-1 negatively regulates epithelial Ca(2 (zeige CA2 ELISA Kits)+) channel gene expression to reduce Ca(2 (zeige CA2 ELISA Kits)+) uptake in zebrafish embryos
Our results demonstrated the contrasting effects of STC1 and STC2 (zeige STC2 ELISA Kits)-derived peptides on human macrophage foam cell formation associated with ACAT1 (zeige ACAT1 ELISA Kits) expression and on HASMC migration.
Ssecretory STC1 enhances metastatic potential of hepatocellular carcinomas via JNK (zeige MAPK8 ELISA Kits) signaling.
Glycolysis from glucose is regulated by hSTC-1, decreasing the adequate supply of glycerol-3-phosphate (G3P) needed for fatty acid esterification and triacylglycerol (TG) storage in brown adipose tissue (BAT (zeige BAAT ELISA Kits)). The decrease of TG capacity synthesis from glucose by hSTC-1 compromises the BAT (zeige BAAT ELISA Kits) thermogenic capacity.
Increased STC1 plasma level represents a hallmark of late-onset preeclampsia; STC1 gene variants modulate placental gene expression and maternal hormone levels.
Latanoprost-induced reduction of intraocular pressure is mediated through the downstream signaling molecule STC-1. When used by itself, STC-1 exhibits ocular hypotensive properties.
Study demonstrates that STC1 is overexpressed in the prostate carcinoma cell lines and suggests that it promotes prostate carcinoma cell proliferation via cyclin E1 (zeige CCNE1 ELISA Kits)/CDK2 (zeige CDK2 ELISA Kits).
In the fed state, STC1 increases the incorporation of (14)C from glucose into lipids in the white retroperitoneal adipose tissue (WRAT). STC1 is one of the hormonal factors that control glucose metabolism in WRAT in the fed state.
STC1 protein is significantly up-regulated in midsecretory endometrial fluid and is dysregulated in eutopic endometrial tissue from women with endometriosis. It is likely regulated by cAMP and may be involved in the pathogenesis of decidualization defects.
STC1 expression is significantly upregulated in human masticatory mucosa during wound healing
elevated STC-1 expression is associated with poor clinical outcome in triple-negative breast cancer (TNBC) patients, and STC-1 is directly involved in the invasiveness of TNBC cells
The temporal and cell type-specific expression of STC1 makes this gene a unique marker for implantation in pigs.
The effect of STC1 on the steroidogenetic pathway in cultured granulosa cells is reported.
Over-expression of STC-1 up-regulated Bcl-2 (zeige BCL2 ELISA Kits) protein expression and slightly down-regulated caspase-3 (zeige CASP3 ELISA Kits) production in the damaged cells. Findings from this study suggest that STC-1 plays a protective role in intestinal cells through an antioxidant mechanism.
theca cell-derived big STC is targeted to the cholesterol/lipid storage droplets of luteal cells to regulate steroidogenesis.
once removed from their normal context within the ovary, luteal cells are capable of synthesizing and secreting big STC.
STC-1 in milk is increased following milk stasis
STC-1 maybe improve anti-inflammation, anti-oxidant and anti-apoptosis activities by affecting reactive oxygen species -mediated pathways, especially the phospho-modifications of the respective proteins, resulting in the increase of Superoxide dismutase (zeige SOD1 ELISA Kits) and reduce of capase-3, p53 (zeige TP53 ELISA Kits), IL-6 (zeige IL6 ELISA Kits) and IFN-gamma (zeige IFNG ELISA Kits).
STC1 blunts bleomycin-induced rise in thrombin protein and activity, diminishes thrombin (zeige F2 ELISA Kits)-induced signaling through PAR1 (zeige F2R ELISA Kits) to ERK (zeige EPHB2 ELISA Kits), and inhibits bleomycin-induced pneumonitis.
Stanniocalcin 1 is expressed in thyroid side population cells and thyroid cancer cells.
Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using Stc1.
Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase (zeige PRKAA2 ELISA Kits)-dependent pathway.
STC1 is an endogenous stress protein that may counteract LPS (zeige TLR4 ELISA Kits)-induced lung injury by inhibiting the inflammatory cascade and inducing antioxidant and antiapoptotic mechanisms.
Remarkably, X-linked genes are not overexpressed in female Stc1(-/-) mice, revealing the existence of a mechanism(s) that can compensate for a persistent XCI deficiency to regulate X-linked gene expression.
Overexpression of stanniocalcin-1 inhibits reactive oxygen species and renal ischemia/reperfusion injury.
STC1 was not crucial for the development of ischemic tolerance triggered by hypoxic preconditioning, or for preserving blood-brain barrier integrity but may be involved in functional recovery after stroke.
This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. The gene contains a 5' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, dwarfism, and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers.